Company Overview

Company name: GreenLight Medicines
Description: Developer of cannabinoid formulations intended to target a range of disease areas. The company develops plant-derived cannabinoid molecules from proprietary strains for medicines and also offers plant oil extraction processes and cannabis cultivation technologies, enabling medical practitioners to treat inflammatory diseases, cancer, and neurological disorders.
Year founded: 2014
Parent company:
Industry: Healthcare | Group: | Code:
Website: www.greenlightmedicines.com
Employees: 7
City: Dublin
State:
Country: Ireland
Region:

Financial Highlights

Start up capital raised (USD Million): 1.80
Business status: Clinical Trials – Phase 1
Ownership: Privately Held (backing)
Exchange:
Ticker:
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status:
Number of active investors:
Profile last updated: 31-Jul-2020
Last known valuation: 8.18
Last known valuation date: 01-Mar-2019